chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was expired upon administration.  Vaccine was thawed and refrigerated starting on 8/26/2022 at 11:15 a.m. and expired on 9/25/2022 at 11:15 a.m.  Dose was administered on 9/26/2022 at 09:00 a.m.    Patient was unharmed and did not show any signs or symptoms of distress.  Patient was notified of expired medication and is currently awaiting follow-up instructions.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal distension, Acute kidney injury, Adrenal insufficiency, Anticoagulant therapy, Atelectasis
Clinical narrative: 2/13/2022-Transfer from LTC, report of AMC, SOB and distended abdomen. Afebrile HR-97. WBC-21.3  CRP-5.5 Covid +. Start baricitinib, IV Decadron, IV azithromycin and cefepime.  2.5 L via NC 02 sat 98%,  Admit- Acute encephalopathy metabolic due to uremia in the setting of dehydration and poor oral intake. AKIBUN 77 CReatnine-1.7 EGFR-31  Chest CT-Bibasilar atelectactic change.  2/15/2022-Titrated down to 2L . Given 2 units PRBC due to excessive bleeding for RLE wound bleeding. H/H 6.6/19.1. 2/16/2022-Baricitinib,decadron and cefepime d/c, pt asymptomatic. 2/18/2022- Tachy HR 150-170. HFpEF exacerbation A fib with RVR: Lasix IV and lopressor once, carvedilol increased to 12.5mg. Placed on bipap, after sat 93% on 5L. 2/18/2022- CXR: possible pluer effusion. ABg: 7.460/38.1/77/27.1/96. Started on Zosyn for older sacral decub with exposed bone concerning for osteo. Am:rapid called. HR in 160's Sob and lethargic. Bipap.  PM: Rapid called, BP in the 70's systolic, pt intubated and transfered to ICU. Pt on neo-synephrine 100 mcg, Levo at 36 mcg. Levo weaned down to 15 mcg and Neo weaned down to 50 mcg to maintain sbp >90. Cm NSR and Temp 99. Hydrocortisone for Cushings.  2/19/2022- Shock st to acute adrenal insufficiency recent systemic corticosteroid taper for large sacral ulcer with osteo.  MSSA and chronic hypoxemic resp failure. AKI. Continue IV piperacillian/tazobactam and IV vanco, for ID coverage. On levo at 40 mcg off IV phenylephrine 100mcg. BP 79/45 and hr 68.  Intubated BiLevel 14/PEEP 8/PS 24cm h20/FIO@ 50%. 2/21/2022-sputum cuture. Continue Zosyn D/C vanco  Extubated. 2L via NC and Bipap at HS .    CR is 1.2 H &H stable. A fib rate controlled, on eliquis.  2/23/2022- ICU downgrade. 2L via NC stable.  2/26/2022- Hgb down to 6.3 tranfused 2 units PRBC.  repeat hgb 8.0. 2/28/2022-Low temp 95.6, D5LR IV.  3/8/2022- Stable on RA, CHFpEF better on LAsix 40 mg. Continue Zosyn for osteo. A fib rate is controlled. 3/15/2022-Stable on RA, BP-117/67 P-86. EFGR  36, WBC 9.8, H &H 7.63/23.1 1 unit PRBC given amd continue Zosyn for osteo. Discharged.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Atrial fibrillation, Azotaemia, Blood creatinine increased, Blood gases, Blood urea increased
Clinical narrative: 2/13/2022-Transfer from LTC, report of AMC, SOB and distended abdomen. Afebrile HR-97. WBC-21.3  CRP-5.5 Covid +. Start baricitinib, IV Decadron, IV azithromycin and cefepime.  2.5 L via NC 02 sat 98%,  Admit- Acute encephalopathy metabolic due to uremia in the setting of dehydration and poor oral intake. AKIBUN 77 CReatnine-1.7 EGFR-31  Chest CT-Bibasilar atelectactic change.  2/15/2022-Titrated down to 2L . Given 2 units PRBC due to excessive bleeding for RLE wound bleeding. H/H 6.6/19.1. 2/16/2022-Baricitinib,decadron and cefepime d/c, pt asymptomatic. 2/18/2022- Tachy HR 150-170. HFpEF exacerbation A fib with RVR: Lasix IV and lopressor once, carvedilol increased to 12.5mg. Placed on bipap, after sat 93% on 5L. 2/18/2022- CXR: possible pluer effusion. ABg: 7.460/38.1/77/27.1/96. Started on Zosyn for older sacral decub with exposed bone concerning for osteo. Am:rapid called. HR in 160's Sob and lethargic. Bipap.  PM: Rapid called, BP in the 70's systolic, pt intubated and transfered to ICU. Pt on neo-synephrine 100 mcg, Levo at 36 mcg. Levo weaned down to 15 mcg and Neo weaned down to 50 mcg to maintain sbp >90. Cm NSR and Temp 99. Hydrocortisone for Cushings.  2/19/2022- Shock st to acute adrenal insufficiency recent systemic corticosteroid taper for large sacral ulcer with osteo.  MSSA and chronic hypoxemic resp failure. AKI. Continue IV piperacillian/tazobactam and IV vanco, for ID coverage. On levo at 40 mcg off IV phenylephrine 100mcg. BP 79/45 and hr 68.  Intubated BiLevel 14/PEEP 8/PS 24cm h20/FIO@ 50%. 2/21/2022-sputum cuture. Continue Zosyn D/C vanco  Extubated. 2L via NC and Bipap at HS .    CR is 1.2 H &H stable. A fib rate controlled, on eliquis.  2/23/2022- ICU downgrade. 2L via NC stable.  2/26/2022- Hgb down to 6.3 tranfused 2 units PRBC.  repeat hgb 8.0. 2/28/2022-Low temp 95.6, D5LR IV.  3/8/2022- Stable on RA, CHFpEF better on LAsix 40 mg. Continue Zosyn for osteo. A fib rate is controlled. 3/15/2022-Stable on RA, BP-117/67 P-86. EFGR  36, WBC 9.8, H &H 7.63/23.1 1 unit PRBC given amd continue Zosyn for osteo. Discharged.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Body temperature decreased, C-reactive protein increased, COVID-19, Cardiac failure, Cardiac failure congestive
Clinical narrative: 2/13/2022-Transfer from LTC, report of AMC, SOB and distended abdomen. Afebrile HR-97. WBC-21.3  CRP-5.5 Covid +. Start baricitinib, IV Decadron, IV azithromycin and cefepime.  2.5 L via NC 02 sat 98%,  Admit- Acute encephalopathy metabolic due to uremia in the setting of dehydration and poor oral intake. AKIBUN 77 CReatnine-1.7 EGFR-31  Chest CT-Bibasilar atelectactic change.  2/15/2022-Titrated down to 2L . Given 2 units PRBC due to excessive bleeding for RLE wound bleeding. H/H 6.6/19.1. 2/16/2022-Baricitinib,decadron and cefepime d/c, pt asymptomatic. 2/18/2022- Tachy HR 150-170. HFpEF exacerbation A fib with RVR: Lasix IV and lopressor once, carvedilol increased to 12.5mg. Placed on bipap, after sat 93% on 5L. 2/18/2022- CXR: possible pluer effusion. ABg: 7.460/38.1/77/27.1/96. Started on Zosyn for older sacral decub with exposed bone concerning for osteo. Am:rapid called. HR in 160's Sob and lethargic. Bipap.  PM: Rapid called, BP in the 70's systolic, pt intubated and transfered to ICU. Pt on neo-synephrine 100 mcg, Levo at 36 mcg. Levo weaned down to 15 mcg and Neo weaned down to 50 mcg to maintain sbp >90. Cm NSR and Temp 99. Hydrocortisone for Cushings.  2/19/2022- Shock st to acute adrenal insufficiency recent systemic corticosteroid taper for large sacral ulcer with osteo.  MSSA and chronic hypoxemic resp failure. AKI. Continue IV piperacillian/tazobactam and IV vanco, for ID coverage. On levo at 40 mcg off IV phenylephrine 100mcg. BP 79/45 and hr 68.  Intubated BiLevel 14/PEEP 8/PS 24cm h20/FIO@ 50%. 2/21/2022-sputum cuture. Continue Zosyn D/C vanco  Extubated. 2L via NC and Bipap at HS .    CR is 1.2 H &H stable. A fib rate controlled, on eliquis.  2/23/2022- ICU downgrade. 2L via NC stable.  2/26/2022- Hgb down to 6.3 tranfused 2 units PRBC.  repeat hgb 8.0. 2/28/2022-Low temp 95.6, D5LR IV.  3/8/2022- Stable on RA, CHFpEF better on LAsix 40 mg. Continue Zosyn for osteo. A fib rate is controlled. 3/15/2022-Stable on RA, BP-117/67 P-86. EFGR  36, WBC 9.8, H &H 7.63/23.1 1 unit PRBC given amd continue Zosyn for osteo. Discharged.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest X-ray abnormal, Computerised tomogram thorax abnormal, Decubitus ulcer, Dehydration, Dyspnoea
Clinical narrative: 2/13/2022-Transfer from LTC, report of AMC, SOB and distended abdomen. Afebrile HR-97. WBC-21.3  CRP-5.5 Covid +. Start baricitinib, IV Decadron, IV azithromycin and cefepime.  2.5 L via NC 02 sat 98%,  Admit- Acute encephalopathy metabolic due to uremia in the setting of dehydration and poor oral intake. AKIBUN 77 CReatnine-1.7 EGFR-31  Chest CT-Bibasilar atelectactic change.  2/15/2022-Titrated down to 2L . Given 2 units PRBC due to excessive bleeding for RLE wound bleeding. H/H 6.6/19.1. 2/16/2022-Baricitinib,decadron and cefepime d/c, pt asymptomatic. 2/18/2022- Tachy HR 150-170. HFpEF exacerbation A fib with RVR: Lasix IV and lopressor once, carvedilol increased to 12.5mg. Placed on bipap, after sat 93% on 5L. 2/18/2022- CXR: possible pluer effusion. ABg: 7.460/38.1/77/27.1/96. Started on Zosyn for older sacral decub with exposed bone concerning for osteo. Am:rapid called. HR in 160's Sob and lethargic. Bipap.  PM: Rapid called, BP in the 70's systolic, pt intubated and transfered to ICU. Pt on neo-synephrine 100 mcg, Levo at 36 mcg. Levo weaned down to 15 mcg and Neo weaned down to 50 mcg to maintain sbp >90. Cm NSR and Temp 99. Hydrocortisone for Cushings.  2/19/2022- Shock st to acute adrenal insufficiency recent systemic corticosteroid taper for large sacral ulcer with osteo.  MSSA and chronic hypoxemic resp failure. AKI. Continue IV piperacillian/tazobactam and IV vanco, for ID coverage. On levo at 40 mcg off IV phenylephrine 100mcg. BP 79/45 and hr 68.  Intubated BiLevel 14/PEEP 8/PS 24cm h20/FIO@ 50%. 2/21/2022-sputum cuture. Continue Zosyn D/C vanco  Extubated. 2L via NC and Bipap at HS .    CR is 1.2 H &H stable. A fib rate controlled, on eliquis.  2/23/2022- ICU downgrade. 2L via NC stable.  2/26/2022- Hgb down to 6.3 tranfused 2 units PRBC.  repeat hgb 8.0. 2/28/2022-Low temp 95.6, D5LR IV.  3/8/2022- Stable on RA, CHFpEF better on LAsix 40 mg. Continue Zosyn for osteo. A fib rate is controlled. 3/15/2022-Stable on RA, BP-117/67 P-86. EFGR  36, WBC 9.8, H &H 7.63/23.1 1 unit PRBC given amd continue Zosyn for osteo. Discharged.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, Glomerular filtration rate decreased, Haematocrit decreased, Haemoglobin decreased, Hypophagia
Clinical narrative: 2/13/2022-Transfer from LTC, report of AMC, SOB and distended abdomen. Afebrile HR-97. WBC-21.3  CRP-5.5 Covid +. Start baricitinib, IV Decadron, IV azithromycin and cefepime.  2.5 L via NC 02 sat 98%,  Admit- Acute encephalopathy metabolic due to uremia in the setting of dehydration and poor oral intake. AKIBUN 77 CReatnine-1.7 EGFR-31  Chest CT-Bibasilar atelectactic change.  2/15/2022-Titrated down to 2L . Given 2 units PRBC due to excessive bleeding for RLE wound bleeding. H/H 6.6/19.1. 2/16/2022-Baricitinib,decadron and cefepime d/c, pt asymptomatic. 2/18/2022- Tachy HR 150-170. HFpEF exacerbation A fib with RVR: Lasix IV and lopressor once, carvedilol increased to 12.5mg. Placed on bipap, after sat 93% on 5L. 2/18/2022- CXR: possible pluer effusion. ABg: 7.460/38.1/77/27.1/96. Started on Zosyn for older sacral decub with exposed bone concerning for osteo. Am:rapid called. HR in 160's Sob and lethargic. Bipap.  PM: Rapid called, BP in the 70's systolic, pt intubated and transfered to ICU. Pt on neo-synephrine 100 mcg, Levo at 36 mcg. Levo weaned down to 15 mcg and Neo weaned down to 50 mcg to maintain sbp >90. Cm NSR and Temp 99. Hydrocortisone for Cushings.  2/19/2022- Shock st to acute adrenal insufficiency recent systemic corticosteroid taper for large sacral ulcer with osteo.  MSSA and chronic hypoxemic resp failure. AKI. Continue IV piperacillian/tazobactam and IV vanco, for ID coverage. On levo at 40 mcg off IV phenylephrine 100mcg. BP 79/45 and hr 68.  Intubated BiLevel 14/PEEP 8/PS 24cm h20/FIO@ 50%. 2/21/2022-sputum cuture. Continue Zosyn D/C vanco  Extubated. 2L via NC and Bipap at HS .    CR is 1.2 H &H stable. A fib rate controlled, on eliquis.  2/23/2022- ICU downgrade. 2L via NC stable.  2/26/2022- Hgb down to 6.3 tranfused 2 units PRBC.  repeat hgb 8.0. 2/28/2022-Low temp 95.6, D5LR IV.  3/8/2022- Stable on RA, CHFpEF better on LAsix 40 mg. Continue Zosyn for osteo. A fib rate is controlled. 3/15/2022-Stable on RA, BP-117/67 P-86. EFGR  36, WBC 9.8, H &H 7.63/23.1 1 unit PRBC given amd continue Zosyn for osteo. Discharged.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Intensive care, Lethargy, Limb injury, Metabolic encephalopathy, Positive airway pressure therapy
Clinical narrative: 2/13/2022-Transfer from LTC, report of AMC, SOB and distended abdomen. Afebrile HR-97. WBC-21.3  CRP-5.5 Covid +. Start baricitinib, IV Decadron, IV azithromycin and cefepime.  2.5 L via NC 02 sat 98%,  Admit- Acute encephalopathy metabolic due to uremia in the setting of dehydration and poor oral intake. AKIBUN 77 CReatnine-1.7 EGFR-31  Chest CT-Bibasilar atelectactic change.  2/15/2022-Titrated down to 2L . Given 2 units PRBC due to excessive bleeding for RLE wound bleeding. H/H 6.6/19.1. 2/16/2022-Baricitinib,decadron and cefepime d/c, pt asymptomatic. 2/18/2022- Tachy HR 150-170. HFpEF exacerbation A fib with RVR: Lasix IV and lopressor once, carvedilol increased to 12.5mg. Placed on bipap, after sat 93% on 5L. 2/18/2022- CXR: possible pluer effusion. ABg: 7.460/38.1/77/27.1/96. Started on Zosyn for older sacral decub with exposed bone concerning for osteo. Am:rapid called. HR in 160's Sob and lethargic. Bipap.  PM: Rapid called, BP in the 70's systolic, pt intubated and transfered to ICU. Pt on neo-synephrine 100 mcg, Levo at 36 mcg. Levo weaned down to 15 mcg and Neo weaned down to 50 mcg to maintain sbp >90. Cm NSR and Temp 99. Hydrocortisone for Cushings.  2/19/2022- Shock st to acute adrenal insufficiency recent systemic corticosteroid taper for large sacral ulcer with osteo.  MSSA and chronic hypoxemic resp failure. AKI. Continue IV piperacillian/tazobactam and IV vanco, for ID coverage. On levo at 40 mcg off IV phenylephrine 100mcg. BP 79/45 and hr 68.  Intubated BiLevel 14/PEEP 8/PS 24cm h20/FIO@ 50%. 2/21/2022-sputum cuture. Continue Zosyn D/C vanco  Extubated. 2L via NC and Bipap at HS .    CR is 1.2 H &H stable. A fib rate controlled, on eliquis.  2/23/2022- ICU downgrade. 2L via NC stable.  2/26/2022- Hgb down to 6.3 tranfused 2 units PRBC.  repeat hgb 8.0. 2/28/2022-Low temp 95.6, D5LR IV.  3/8/2022- Stable on RA, CHFpEF better on LAsix 40 mg. Continue Zosyn for osteo. A fib rate is controlled. 3/15/2022-Stable on RA, BP-117/67 P-86. EFGR  36, WBC 9.8, H &H 7.63/23.1 1 unit PRBC given amd continue Zosyn for osteo. Discharged.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Red blood cell transfusion, Respiratory failure, SARS-CoV-2 test positive, Shock, Sputum culture
Clinical narrative: 2/13/2022-Transfer from LTC, report of AMC, SOB and distended abdomen. Afebrile HR-97. WBC-21.3  CRP-5.5 Covid +. Start baricitinib, IV Decadron, IV azithromycin and cefepime.  2.5 L via NC 02 sat 98%,  Admit- Acute encephalopathy metabolic due to uremia in the setting of dehydration and poor oral intake. AKIBUN 77 CReatnine-1.7 EGFR-31  Chest CT-Bibasilar atelectactic change.  2/15/2022-Titrated down to 2L . Given 2 units PRBC due to excessive bleeding for RLE wound bleeding. H/H 6.6/19.1. 2/16/2022-Baricitinib,decadron and cefepime d/c, pt asymptomatic. 2/18/2022- Tachy HR 150-170. HFpEF exacerbation A fib with RVR: Lasix IV and lopressor once, carvedilol increased to 12.5mg. Placed on bipap, after sat 93% on 5L. 2/18/2022- CXR: possible pluer effusion. ABg: 7.460/38.1/77/27.1/96. Started on Zosyn for older sacral decub with exposed bone concerning for osteo. Am:rapid called. HR in 160's Sob and lethargic. Bipap.  PM: Rapid called, BP in the 70's systolic, pt intubated and transfered to ICU. Pt on neo-synephrine 100 mcg, Levo at 36 mcg. Levo weaned down to 15 mcg and Neo weaned down to 50 mcg to maintain sbp >90. Cm NSR and Temp 99. Hydrocortisone for Cushings.  2/19/2022- Shock st to acute adrenal insufficiency recent systemic corticosteroid taper for large sacral ulcer with osteo.  MSSA and chronic hypoxemic resp failure. AKI. Continue IV piperacillian/tazobactam and IV vanco, for ID coverage. On levo at 40 mcg off IV phenylephrine 100mcg. BP 79/45 and hr 68.  Intubated BiLevel 14/PEEP 8/PS 24cm h20/FIO@ 50%. 2/21/2022-sputum cuture. Continue Zosyn D/C vanco  Extubated. 2L via NC and Bipap at HS .    CR is 1.2 H &H stable. A fib rate controlled, on eliquis.  2/23/2022- ICU downgrade. 2L via NC stable.  2/26/2022- Hgb down to 6.3 tranfused 2 units PRBC.  repeat hgb 8.0. 2/28/2022-Low temp 95.6, D5LR IV.  3/8/2022- Stable on RA, CHFpEF better on LAsix 40 mg. Continue Zosyn for osteo. A fib rate is controlled. 3/15/2022-Stable on RA, BP-117/67 P-86. EFGR  36, WBC 9.8, H &H 7.63/23.1 1 unit PRBC given amd continue Zosyn for osteo. Discharged.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Staphylococcal infection, Tachycardia, White blood cell count increased, Wound haemorrhage
Clinical narrative: 2/13/2022-Transfer from LTC, report of AMC, SOB and distended abdomen. Afebrile HR-97. WBC-21.3  CRP-5.5 Covid +. Start baricitinib, IV Decadron, IV azithromycin and cefepime.  2.5 L via NC 02 sat 98%,  Admit- Acute encephalopathy metabolic due to uremia in the setting of dehydration and poor oral intake. AKIBUN 77 CReatnine-1.7 EGFR-31  Chest CT-Bibasilar atelectactic change.  2/15/2022-Titrated down to 2L . Given 2 units PRBC due to excessive bleeding for RLE wound bleeding. H/H 6.6/19.1. 2/16/2022-Baricitinib,decadron and cefepime d/c, pt asymptomatic. 2/18/2022- Tachy HR 150-170. HFpEF exacerbation A fib with RVR: Lasix IV and lopressor once, carvedilol increased to 12.5mg. Placed on bipap, after sat 93% on 5L. 2/18/2022- CXR: possible pluer effusion. ABg: 7.460/38.1/77/27.1/96. Started on Zosyn for older sacral decub with exposed bone concerning for osteo. Am:rapid called. HR in 160's Sob and lethargic. Bipap.  PM: Rapid called, BP in the 70's systolic, pt intubated and transfered to ICU. Pt on neo-synephrine 100 mcg, Levo at 36 mcg. Levo weaned down to 15 mcg and Neo weaned down to 50 mcg to maintain sbp >90. Cm NSR and Temp 99. Hydrocortisone for Cushings.  2/19/2022- Shock st to acute adrenal insufficiency recent systemic corticosteroid taper for large sacral ulcer with osteo.  MSSA and chronic hypoxemic resp failure. AKI. Continue IV piperacillian/tazobactam and IV vanco, for ID coverage. On levo at 40 mcg off IV phenylephrine 100mcg. BP 79/45 and hr 68.  Intubated BiLevel 14/PEEP 8/PS 24cm h20/FIO@ 50%. 2/21/2022-sputum cuture. Continue Zosyn D/C vanco  Extubated. 2L via NC and Bipap at HS .    CR is 1.2 H &H stable. A fib rate controlled, on eliquis.  2/23/2022- ICU downgrade. 2L via NC stable.  2/26/2022- Hgb down to 6.3 tranfused 2 units PRBC.  repeat hgb 8.0. 2/28/2022-Low temp 95.6, D5LR IV.  3/8/2022- Stable on RA, CHFpEF better on LAsix 40 mg. Continue Zosyn for osteo. A fib rate is controlled. 3/15/2022-Stable on RA, BP-117/67 P-86. EFGR  36, WBC 9.8, H &H 7.63/23.1 1 unit PRBC given amd continue Zosyn for osteo. Discharged.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Alcohol withdrawal syndrome, Blood creatinine increased, Blood gases, Blood glucose increased
Clinical narrative: 3/23/2022- Presents to ER, with vomiting, etoh withdrawal and cough. Covid + ,  O2 sat dropped to 59%  ABG: 7.11 / 17.3/149/5.5-15.0  4 L via NC, EGFR-42 and BUN/creatnine: 20/14 and glucose 346. Admit Covid , DKA and AKI. Start dexamethasone and Sotrivumab.  3/25/2022- AKI resolved- BUN/creatnine: 10/0.6 and EGFR >60. Spo2 97% on RA.  3/27/2022-  Covid symptoms improved, O2 sat wnl on RA. Waiting on hyperglycemia to stabilize to discharge: 510. 3/28/2022- Discharged to home. Glucose 185.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood urea normal, COVID-19, Cough, Diabetic ketoacidosis, Glomerular filtration rate decreased
Clinical narrative: 3/23/2022- Presents to ER, with vomiting, etoh withdrawal and cough. Covid + ,  O2 sat dropped to 59%  ABG: 7.11 / 17.3/149/5.5-15.0  4 L via NC, EGFR-42 and BUN/creatnine: 20/14 and glucose 346. Admit Covid , DKA and AKI. Start dexamethasone and Sotrivumab.  3/25/2022- AKI resolved- BUN/creatnine: 10/0.6 and EGFR >60. Spo2 97% on RA.  3/27/2022-  Covid symptoms improved, O2 sat wnl on RA. Waiting on hyperglycemia to stabilize to discharge: 510. 3/28/2022- Discharged to home. Glucose 185.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hyperglycaemia, Oxygen saturation decreased, SARS-CoV-2 test positive, Vomiting
Clinical narrative: 3/23/2022- Presents to ER, with vomiting, etoh withdrawal and cough. Covid + ,  O2 sat dropped to 59%  ABG: 7.11 / 17.3/149/5.5-15.0  4 L via NC, EGFR-42 and BUN/creatnine: 20/14 and glucose 346. Admit Covid , DKA and AKI. Start dexamethasone and Sotrivumab.  3/25/2022- AKI resolved- BUN/creatnine: 10/0.6 and EGFR >60. Spo2 97% on RA.  3/27/2022-  Covid symptoms improved, O2 sat wnl on RA. Waiting on hyperglycemia to stabilize to discharge: 510. 3/28/2022- Discharged to home. Glucose 185.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Blood creatinine increased, Blood urea increased, COVID-19, Cardiac failure congestive
Clinical narrative: 4/23/2022-Presents to ED, c/o SOB, cough and dizziness.  Saw pcp 4/22/2022 given Doxy  100mg tab and Prednisone for possible bronchitis.  In ED, wbc 13.3. Covid +. Baseline 2L vi aNC. CXR: hilar congestion and blunted left costophrenic angle. Received Remdesivir, lasix, azithromycin and  ceftriaxone. AKI creatnine 1.3, BUN 27 and eGFR 41. O2 sat at RA 94-98%. Admit chronic resp failure complicated by Covid and CHF exacerbation. 4/24/2022- Add Decadron vitals WNL. O2 stable on RA. Cpap for OSA. 4/25/2022-D/C to home, baseline o2 use, cefdinir and continue prednisone and doxy.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Chronic respiratory failure, Condition aggravated, Cough, Dizziness
Clinical narrative: 4/23/2022-Presents to ED, c/o SOB, cough and dizziness.  Saw pcp 4/22/2022 given Doxy  100mg tab and Prednisone for possible bronchitis.  In ED, wbc 13.3. Covid +. Baseline 2L vi aNC. CXR: hilar congestion and blunted left costophrenic angle. Received Remdesivir, lasix, azithromycin and  ceftriaxone. AKI creatnine 1.3, BUN 27 and eGFR 41. O2 sat at RA 94-98%. Admit chronic resp failure complicated by Covid and CHF exacerbation. 4/24/2022- Add Decadron vitals WNL. O2 stable on RA. Cpap for OSA. 4/25/2022-D/C to home, baseline o2 use, cefdinir and continue prednisone and doxy.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Glomerular filtration rate normal, Obstructive sleep apnoea syndrome, Positive airway pressure therapy, Pulmonary congestion
Clinical narrative: 4/23/2022-Presents to ED, c/o SOB, cough and dizziness.  Saw pcp 4/22/2022 given Doxy  100mg tab and Prednisone for possible bronchitis.  In ED, wbc 13.3. Covid +. Baseline 2L vi aNC. CXR: hilar congestion and blunted left costophrenic angle. Received Remdesivir, lasix, azithromycin and  ceftriaxone. AKI creatnine 1.3, BUN 27 and eGFR 41. O2 sat at RA 94-98%. Admit chronic resp failure complicated by Covid and CHF exacerbation. 4/24/2022- Add Decadron vitals WNL. O2 stable on RA. Cpap for OSA. 4/25/2022-D/C to home, baseline o2 use, cefdinir and continue prednisone and doxy.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, White blood cell count increased
Clinical narrative: 4/23/2022-Presents to ED, c/o SOB, cough and dizziness.  Saw pcp 4/22/2022 given Doxy  100mg tab and Prednisone for possible bronchitis.  In ED, wbc 13.3. Covid +. Baseline 2L vi aNC. CXR: hilar congestion and blunted left costophrenic angle. Received Remdesivir, lasix, azithromycin and  ceftriaxone. AKI creatnine 1.3, BUN 27 and eGFR 41. O2 sat at RA 94-98%. Admit chronic resp failure complicated by Covid and CHF exacerbation. 4/24/2022- Add Decadron vitals WNL. O2 stable on RA. Cpap for OSA. 4/25/2022-D/C to home, baseline o2 use, cefdinir and continue prednisone and doxy.
Age: 26.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Bright red, warm to touch, extremely itchy and raised at injection site. Was approximately the size of a golf ball has been going on for 4 days and still present. Has been taking an allergy pill daily since 9/22/22 to reduce swelling and itching.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Migraine, Vomiting
Clinical narrative: Vomiting for ten hours straight, severe migraine
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Tenderness
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Tenderness, shoulder pain-Medium
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine  breakthrough  dose 1 2/28/21  025A21A dose 2 3/24/21  045A21A dose 3 9/1/21  050C21A
Age: 44.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 68.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site bruising, Injection site pain, Injection site pruritus, Injection site swelling, Pruritus
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Itch Generalized-Medium, Additional Details: pt. got 2 vaccinations on the same time (flu shot and Prevnar 20)
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 50.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Chills, Dizziness, Myalgia, Pyrexia
Clinical narrative: Woke up at 2am with fever, chills, muscle ache, joint pain and dizziness.  Fever broke around 9:30am.  The rest of the day until going to bed at approx 10pm continued with muscle ache and joint pain.
Age: 50.0
Sex: M
Vaccine: VARZOS
Symptoms: Sleep disorder
Clinical narrative: Woke up at 2am with fever, chills, muscle ache, joint pain and dizziness.  Fever broke around 9:30am.  The rest of the day until going to bed at approx 10pm continued with muscle ache and joint pain.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: PATIENT DENIES ANY SIDE EFFECTS MONOVALENT DOSE GIVEN - SHOULD HAVE BEEN BIVALENT - PATIENT WILL RETURN IN 2 MONTHS TO RECEIVE CORRECT VACCINE.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse event.  Dose was drawn up and sent to nursing unit on 9/13/2022 around 1500.  Nurse did not realize dose was to be given immediately, so it was placed in the fridge.  The dose was pulled from the fridge and given on 9/14/2022 around 1200 prior to patient discharge.  Nurse did not know to request a new vaccine from pharmacy.  Pharmacy did not realize this happened until 9/15/2022 when looking at documentation in registry. Will contact patient.  Does patient need an additional booster at this time?
Age: 53.0
Sex: F
Vaccine: TDAP
Symptoms: Decreased appetite, Fatigue, Hyperhidrosis, Liver function test increased, Nausea
Clinical narrative: high fever, severe fatigue, elevated LFTs, nausea and loss of appetite, soaking and severe night sweats beginning the evening after vaccine administration
Age: 53.0
Sex: F
Vaccine: TDAP
Symptoms: Night sweats, Pyrexia
Clinical narrative: high fever, severe fatigue, elevated LFTs, nausea and loss of appetite, soaking and severe night sweats beginning the evening after vaccine administration
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Cardiac failure congestive, Chest discomfort, Coronary angioplasty, Left ventricular dysfunction
Clinical narrative: I had weird feeling sensations in my chest for a couple weeks before the heart attack after the vaccination I was hospitalized and diagnosed with congestive heart failure and that I have an 2nd heart attack in April of 2022 where they went through my wrist and balloon to my artery some more. I'm still in the process of being treated for the congestive heart failure that I now suffer from due to the vaccine.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Myocardial infarction
Clinical narrative: I had weird feeling sensations in my chest for a couple weeks before the heart attack after the vaccination I was hospitalized and diagnosed with congestive heart failure and that I have an 2nd heart attack in April of 2022 where they went through my wrist and balloon to my artery some more. I'm still in the process of being treated for the congestive heart failure that I now suffer from due to the vaccine.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Injection site cellulitis
Clinical narrative: PATIENT HAD A CELLULITIS DEVELOP AT THE SITE OF THE INJECTION
Age: 58.0
Sex: M
Vaccine: COVID19-2
Symptoms: Fatigue, Glossodynia, Pain in extremity, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: After 2 days of the common AEs of painful arm, fatigue, low fever, I developed a painful tongue, which has been persisting.
Age: 42.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Anxiety, Condition aggravated, Depressive symptom, Feeling abnormal, Impaired work ability
Clinical narrative: Both the flu and COVID bivalent shots were given at the same time in different locations on Wednesday, September 21, 2022. The patient states, "I am established with psychiatry and a primary care provider and therapist. I see these professionals regularly and am on daily medications for anxiety and depression.  I woke up on Thursday and was not myself. I realized Thursday evening that not only was I achy but I was having extreme anxiety and depression symptoms. Friday afternoon I realized I was feeling suicidal and needed to complete my workday at home and be in the presence of supportive people to keep me safe. These feelings continued into the weekend. I slept for 9 hours Saturday evening and woke up on Sunday morning feeling like a new human, no body aches and no anxiety or depression symptoms."
Age: 42.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Pain, Suicidal ideation
Clinical narrative: Both the flu and COVID bivalent shots were given at the same time in different locations on Wednesday, September 21, 2022. The patient states, "I am established with psychiatry and a primary care provider and therapist. I see these professionals regularly and am on daily medications for anxiety and depression.  I woke up on Thursday and was not myself. I realized Thursday evening that not only was I achy but I was having extreme anxiety and depression symptoms. Friday afternoon I realized I was feeling suicidal and needed to complete my workday at home and be in the presence of supportive people to keep me safe. These feelings continued into the weekend. I slept for 9 hours Saturday evening and woke up on Sunday morning feeling like a new human, no body aches and no anxiety or depression symptoms."
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoaesthesia, Immediate post-injection reaction, Oedema peripheral, Paraesthesia, Tenderness
Clinical narrative: tingling numbness in fingers right after injection , swollen under arm/tenderness to touch continued and still exist 3 days after injection
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Called client and informed her that she was given the wrong Pfizer. Recommend to get Bivalent in 2 months.
Age: 67.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Injection site pain, Injection site rash
Clinical narrative: Patient developed a rash on their left arm right around the site of administration. Rash developed about 5-6 days after receiving both injections. No itching was noticed by the patient but the soreness occurred for the next 3 days. Pateint received a 10 day course of Cephalexin in which she reported that it started to clear up by day 2. On completion of the 10 day course patient reported that the rash was fully cleared.
Age: 86.0
Sex: F
Vaccine: COVID19, HEPA, VARZOS
Symptoms: COVID-19, Chest X-ray normal, Chronic obstructive pulmonary disease, Condition aggravated, Dyspnoea
Clinical narrative: Admission Date: 9/19/2022 Discharge Date: Sep 22, 2022 PRESENTING PROBLEM: Hypoxia [R09.02] COPD with acute exacerbation (HCC) [J44.1] COVID-19 [U07.1]   HOSPITAL COURSE: HOSPITAL COURSE: Patient is an 86-year-old female with COPD (not on home oxygen), hypertension, chronic low back pain and ongoing tobacco abuse who presented with worsening shortness of breath.  She had been placed on a Prednisone burst by her outpatient pulmonologist on 9/15 with no significant improvement in symptoms, so presented to the ED on 9/19.  In the ED, her oxygen saturations dropped to 85% on room air and was placed on 1 L oxygen.  She was hypertensive in the ED with blood pressure 203/81.  She was found to be COVID positive.  Chest x-ray showed no acute cardiopulmonary process.  Due to her hypoxia and ongoing dyspnea with wheezing, she was admitted to the hospitalist service for further care.   Upon admission, she was continued on supplemental oxygen. She was started on Decadron 6 mg daily and IV Remdesivir for COVID-19.  She continued to require 2 L oxygen with activity, but admitted to slow improvement in her respiratory symptoms.   She was felt stable for discharge on 9/22. at that time she her only complaint was dyspnea on exertion and this had improved since admission, she was also requiring oxygen with exertion. she was sent out on two more days of azithromycin as well as seven more days of decadron to be followed by a taper. she was also instructed to see her PCP. at the time of discharge patient had no objections to discharge. all questions and concerns addressed, all meds and follow-ups reviewed.
Age: 86.0
Sex: F
Vaccine: COVID19, HEPA, VARZOS
Symptoms: Dyspnoea exertional, Hypertension, Hypoxia, Oxygen saturation decreased, SARS-CoV-2 test positive
Clinical narrative: Admission Date: 9/19/2022 Discharge Date: Sep 22, 2022 PRESENTING PROBLEM: Hypoxia [R09.02] COPD with acute exacerbation (HCC) [J44.1] COVID-19 [U07.1]   HOSPITAL COURSE: HOSPITAL COURSE: Patient is an 86-year-old female with COPD (not on home oxygen), hypertension, chronic low back pain and ongoing tobacco abuse who presented with worsening shortness of breath.  She had been placed on a Prednisone burst by her outpatient pulmonologist on 9/15 with no significant improvement in symptoms, so presented to the ED on 9/19.  In the ED, her oxygen saturations dropped to 85% on room air and was placed on 1 L oxygen.  She was hypertensive in the ED with blood pressure 203/81.  She was found to be COVID positive.  Chest x-ray showed no acute cardiopulmonary process.  Due to her hypoxia and ongoing dyspnea with wheezing, she was admitted to the hospitalist service for further care.   Upon admission, she was continued on supplemental oxygen. She was started on Decadron 6 mg daily and IV Remdesivir for COVID-19.  She continued to require 2 L oxygen with activity, but admitted to slow improvement in her respiratory symptoms.   She was felt stable for discharge on 9/22. at that time she her only complaint was dyspnea on exertion and this had improved since admission, she was also requiring oxygen with exertion. she was sent out on two more days of azithromycin as well as seven more days of decadron to be followed by a taper. she was also instructed to see her PCP. at the time of discharge patient had no objections to discharge. all questions and concerns addressed, all meds and follow-ups reviewed.
Age: 86.0
Sex: F
Vaccine: COVID19, HEPA, VARZOS
Symptoms: Wheezing
Clinical narrative: Admission Date: 9/19/2022 Discharge Date: Sep 22, 2022 PRESENTING PROBLEM: Hypoxia [R09.02] COPD with acute exacerbation (HCC) [J44.1] COVID-19 [U07.1]   HOSPITAL COURSE: HOSPITAL COURSE: Patient is an 86-year-old female with COPD (not on home oxygen), hypertension, chronic low back pain and ongoing tobacco abuse who presented with worsening shortness of breath.  She had been placed on a Prednisone burst by her outpatient pulmonologist on 9/15 with no significant improvement in symptoms, so presented to the ED on 9/19.  In the ED, her oxygen saturations dropped to 85% on room air and was placed on 1 L oxygen.  She was hypertensive in the ED with blood pressure 203/81.  She was found to be COVID positive.  Chest x-ray showed no acute cardiopulmonary process.  Due to her hypoxia and ongoing dyspnea with wheezing, she was admitted to the hospitalist service for further care.   Upon admission, she was continued on supplemental oxygen. She was started on Decadron 6 mg daily and IV Remdesivir for COVID-19.  She continued to require 2 L oxygen with activity, but admitted to slow improvement in her respiratory symptoms.   She was felt stable for discharge on 9/22. at that time she her only complaint was dyspnea on exertion and this had improved since admission, she was also requiring oxygen with exertion. she was sent out on two more days of azithromycin as well as seven more days of decadron to be followed by a taper. she was also instructed to see her PCP. at the time of discharge patient had no objections to discharge. all questions and concerns addressed, all meds and follow-ups reviewed.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Atelectasis, Chest X-ray abnormal, Dyspnoea, Pyrexia, Total lung capacity decreased
Clinical narrative: Fever, shortness of breath  started 230pm. SPO2  75% on RA, O2 started 2L NC sats  uo to 84% then increased to 3LNC up to  sats 94%
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Condition aggravated, Loss of personal independence in daily activities, Magnetic resonance imaging head abnormal
Clinical narrative: Admission Date: 9/18/2022 Discharge Date: 09/22/2022  DISCHARGE DIAGNOSES 1. Generalized weakness - improved 2. COVID 3. Multiple Sclerosis 4. Essential HTN 5. Depression  HOSPITAL COURSE: Patient is a 61 y.o. male who presented with generalized weakness in the setting of severe multiple sclerosis and was admitted for observation. He did not have other significant COVID signs or symptoms. He is wheelchair bound at baseline, self sufficient in transfers, but on admission was not able to complete self transfers. Neurology recommended brain and cervical spine MRI to rule out any relapse of MS. MRI brain showed Moderate volume right matter signal abnormality compatible with history of multiple sclerosis. No lesion enhancement. Therefore, generalized weakness was attributed to COVID infection. Patient was started on started solumedrol 40 mg IV q8 on 9/20 to help improve symptoms due to COVID, and given his history of multiple sclerosis.  Patient continued to improve with working with PT/OT, and it was determined that he could be discharged home safely with home health.    Patient sent home to complete 7 day course of oral prednisone 40 mg. Patient discharged with home health/PT in place. He was discharged in stable condition, back to near baseline function.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Multiple sclerosis
Clinical narrative: Admission Date: 9/18/2022 Discharge Date: 09/22/2022  DISCHARGE DIAGNOSES 1. Generalized weakness - improved 2. COVID 3. Multiple Sclerosis 4. Essential HTN 5. Depression  HOSPITAL COURSE: Patient is a 61 y.o. male who presented with generalized weakness in the setting of severe multiple sclerosis and was admitted for observation. He did not have other significant COVID signs or symptoms. He is wheelchair bound at baseline, self sufficient in transfers, but on admission was not able to complete self transfers. Neurology recommended brain and cervical spine MRI to rule out any relapse of MS. MRI brain showed Moderate volume right matter signal abnormality compatible with history of multiple sclerosis. No lesion enhancement. Therefore, generalized weakness was attributed to COVID infection. Patient was started on started solumedrol 40 mg IV q8 on 9/20 to help improve symptoms due to COVID, and given his history of multiple sclerosis.  Patient continued to improve with working with PT/OT, and it was determined that he could be discharged home safely with home health.    Patient sent home to complete 7 day course of oral prednisone 40 mg. Patient discharged with home health/PT in place. He was discharged in stable condition, back to near baseline function.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood pressure increased
Clinical narrative: Elevated BP 170/100 increased meds dropped to 150/95
Age: 3.0
Sex: M
Vaccine: DTAPIPV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Kinrix administered to pt. prior to 4th birthday. - Due for DTaP -  Administered on 9/1/22 - No adverse reaction occurred
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Blindness unilateral, Echocardiogram normal, Magnetic resonance imaging head normal, Radiotherapy, Scan normal
Clinical narrative: I have been on radiation since 01/20/2022. I have had 13 rounds of radiation by 02/08/2022. Beginning on 02/08/2022 at dinner time, I lost vision on my right eye. It just sort of bubbled out. I waited only minutes before heading to the emergency room. My eye cleared, like a tank draining. It just came back from the top to the bottom, like a draining tank, so I went home before even reaching the emergency room. The next morning, I called my radiologist to inform him of my eye issue. I also called my eye doctor who wanted to see me right away, but the radiologist set up a scan for my legs to check for blood clots. My eye doctor switched the scan from my legs to my carotid artery. The carotid artery looked fine, and my eye appears to be fine, so the vision loss was sort of a mystery. I have an appointment for the leg scan in the near future. My radiologist says that there is no way that radiation would have caused the vision loss and presumes there was some sort of blood clot. My oncologist insisted that I do not go on blood thinners as my radiologist recommended. I have not had any problems with my eye since then. On 02.14.22 my primary care physician contacted me after hearing of all these events from my other doctors and insisted that I go immediately to the emergency room. At the emergency room, I had blood work and an MRI of the brain and there was no indication of a stroke. I was also advised to see my cardiologist. I made an appointment with him, and I will be getting more tests done with him to see if I have a hole in my heart which would have allowed a blood clot to travel from my leg to my brain. By 02.18.2022 I had a disc implanted to monitor my heart. I also had an echocardiogram to check for that hole in my heart. I was prescribed a statin and an aspirin regimen. No issues were found with my heart.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound Doppler normal
Clinical narrative: I have been on radiation since 01/20/2022. I have had 13 rounds of radiation by 02/08/2022. Beginning on 02/08/2022 at dinner time, I lost vision on my right eye. It just sort of bubbled out. I waited only minutes before heading to the emergency room. My eye cleared, like a tank draining. It just came back from the top to the bottom, like a draining tank, so I went home before even reaching the emergency room. The next morning, I called my radiologist to inform him of my eye issue. I also called my eye doctor who wanted to see me right away, but the radiologist set up a scan for my legs to check for blood clots. My eye doctor switched the scan from my legs to my carotid artery. The carotid artery looked fine, and my eye appears to be fine, so the vision loss was sort of a mystery. I have an appointment for the leg scan in the near future. My radiologist says that there is no way that radiation would have caused the vision loss and presumes there was some sort of blood clot. My oncologist insisted that I do not go on blood thinners as my radiologist recommended. I have not had any problems with my eye since then. On 02.14.22 my primary care physician contacted me after hearing of all these events from my other doctors and insisted that I go immediately to the emergency room. At the emergency room, I had blood work and an MRI of the brain and there was no indication of a stroke. I was also advised to see my cardiologist. I made an appointment with him, and I will be getting more tests done with him to see if I have a hole in my heart which would have allowed a blood clot to travel from my leg to my brain. By 02.18.2022 I had a disc implanted to monitor my heart. I also had an echocardiogram to check for that hole in my heart. I was prescribed a statin and an aspirin regimen. No issues were found with my heart.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Asthenia, COVID-19, Chest X-ray abnormal
Clinical narrative: Admission Date: 9/19/2022 Discharge Date: 9/25/2022  PRESENTING PROBLEM: COVID-19 [U07.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE:  Patient is a very pleasantly confused 80-year-old gentleman who presented with weakness and confusion on admission in the setting of advanced dementia, diabetes mellitus type 2, hypertension.  The patient was diagnosed with COVID-19 infection.  And was in isolation per hospital protocol.  It was also noted that patient drank about 4-5 drinks of whiskey per day.  Patient mentation waxed and waned.  He did not require any supplemental oxygen or required additional treatment per hospital protocol.  Patient was placed on CIWA protocol.  Patient initially was given high-dose thiamine given his heavy alcohol use with no effect.  Care manager was working with family to secure a rehab that will accept a COVID patient with hopes of bringing the patient back home.  Given patient's dementia and comorbidities palliative Care was called to talk to family and will follow-up when patient returns home.  Currently his wife is taking care of him however she also has COVID and he was more than she could handle at that time but they do wish that patient would be able to return home.  Chest x-ray did show left basilar opacities and we will repeat that chest x-ray.  We will discharge the patient on Ceftin and doxycycline to complete a 5 day course.  Patient had elevated AST 19-- >159-- >104.  Patient had elevated ALT 15-- >152-- >126.  Needs to be monitored by SAR and PCP.  Further workup is needed outpatient.  Patient's family was updated by care manager.  Patient was accepted into a COVID facility for rehab.  Patient was discharged in good condition.   His anticipated discharge is 830 on September 25, 2022
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Exposure to SARS-CoV-2, Lung opacity, Mental status changes, Multimorbidity
Clinical narrative: Admission Date: 9/19/2022 Discharge Date: 9/25/2022  PRESENTING PROBLEM: COVID-19 [U07.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE:  Patient is a very pleasantly confused 80-year-old gentleman who presented with weakness and confusion on admission in the setting of advanced dementia, diabetes mellitus type 2, hypertension.  The patient was diagnosed with COVID-19 infection.  And was in isolation per hospital protocol.  It was also noted that patient drank about 4-5 drinks of whiskey per day.  Patient mentation waxed and waned.  He did not require any supplemental oxygen or required additional treatment per hospital protocol.  Patient was placed on CIWA protocol.  Patient initially was given high-dose thiamine given his heavy alcohol use with no effect.  Care manager was working with family to secure a rehab that will accept a COVID patient with hopes of bringing the patient back home.  Given patient's dementia and comorbidities palliative Care was called to talk to family and will follow-up when patient returns home.  Currently his wife is taking care of him however she also has COVID and he was more than she could handle at that time but they do wish that patient would be able to return home.  Chest x-ray did show left basilar opacities and we will repeat that chest x-ray.  We will discharge the patient on Ceftin and doxycycline to complete a 5 day course.  Patient had elevated AST 19-- >159-- >104.  Patient had elevated ALT 15-- >152-- >126.  Needs to be monitored by SAR and PCP.  Further workup is needed outpatient.  Patient's family was updated by care manager.  Patient was accepted into a COVID facility for rehab.  Patient was discharged in good condition.   His anticipated discharge is 830 on September 25, 2022
Age: 58.0
Sex: M
Vaccine: FLUC4
Symptoms: Musculoskeletal pain, Neck pain, Pain in extremity
Clinical narrative: having constant pain down left arm and left side of neck, bottom of shoulder blade to finger tips